egnite Obtains Patent for NLP Mitral Regurgitation Classifier
egnite received U.S. Patent No. 12,580,057 for a hierarchical, rules-based NLP algorithm that classifies mitral regurgitation (MR) mechanism from echocardiographic report text. Validated on a subset of 5.5 million deidentified echo reports, the classifier achieves 97.3% accuracy in a maximal (population-capture) mode and 99.0% in a minimal (highest-confidence) mode. The model is deployed across more than 600 U.S. healthcare facilities and encodes ACC/AHA guideline logic curated by cardiovascular specialists. The patent targets a clear clinical gap — only 4% of echo reports explicitly state MR etiology — enabling systematic identification of surgical and transcatheter candidates at scale and shortening the window to intervention for at-risk patients.
Scoring Rationale
This is a notable, practitioner-relevant development in clinical NLP and cardiovascular AI: patented algorithm, large-scale validation, and wide deployment. It is not a field-defining foundational model breakthrough, but materially affects operational patient-finding and CDS in cardiology.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read Original?egnite, Inc. Receives U.S. Patent for NLP-Based Algorithm That Classifies Mitral Regurgitation Mechanism from Echocardiographic Reports